Privia Health Group, Inc. Deferred Income Tax Expense (Benefit)
Privia Health Group, Inc. (PRVA) reported Deferred Income Tax Expense (Benefit) of $3.68 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-06
- Privia Health Group, Inc. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was $1.16M, a 20.56% increase year-over-year.
- Privia Health Group, Inc. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $2.53M, a 47.58% increase year-over-year.
- Privia Health Group, Inc. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $1.53M, a 29.34% increase year-over-year.
- Privia Health Group, Inc. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $6.67M, a 78.47% increase year-over-year.
- Privia Health Group, Inc. deferred income tax expense (benefit) for fiscal 2025 was $10.87M, a 23.30% increase from fiscal 2024.
- Privia Health Group, Inc. deferred income tax expense (benefit) for fiscal 2024 was $8.82M, a 18.11% increase from fiscal 2023.
- Privia Health Group, Inc. deferred income tax expense (benefit) for fiscal 2023 was $7.46M.
- Privia Health Group, Inc. deferred income tax expense (benefit) for fiscal 2022 was -$7.00M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.68M 10-Q · filed 2026-08-06 | $5.22M derived: sum of 3 quarters · filed 2026-08-06 | $11.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.53M 10-Q · filed 2026-05-07 | $4.06M derived: sum of 2 quarters · filed 2026-05-07 | $10.73M derived: sum of 3 quarters · filed 2026-05-07 | $11.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $8.20M derived: sum of 2 quarters · filed 2026-02-27 | $9.16M derived: sum of 3 quarters · filed 2026-08-06 | $10.87M 10-K · filed 2026-02-27 |
| 2025-09-30 | $6.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $7.62M derived: sum of 2 quarters · filed 2026-08-06 | $9.34M 10-Q · filed 2025-11-06 | $10.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $958.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.67M 10-Q · filed 2026-08-06 | $3.86M derived: sum of 3 quarters · filed 2026-08-06 | $7.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.71M 10-Q · filed 2026-05-07 | $2.90M derived: sum of 2 quarters · filed 2026-05-07 | $6.63M derived: sum of 3 quarters · filed 2026-05-07 | $9.67M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.92M derived: sum of 2 quarters · filed 2026-02-27 | $7.95M derived: sum of 3 quarters · filed 2026-02-27 | $8.82M 10-K · filed 2026-02-27 |
| 2024-09-30 | $3.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $6.77M derived: sum of 2 quarters · filed 2025-11-06 | $7.63M 10-Q · filed 2025-11-06 | $9.92M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $3.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.90M 10-Q · filed 2025-08-07 | $6.18M derived: sum of 3 quarters · filed 2026-02-27 | $8.10M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $863.00K 10-Q · filed 2025-05-08 | $3.15M derived: sum of 2 quarters · filed 2026-02-27 | $5.07M derived: sum of 3 quarters · filed 2026-02-27 | $6.46M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.21M derived: sum of 2 quarters · filed 2026-02-27 | $5.60M derived: sum of 3 quarters · filed 2026-02-27 | $7.46M 10-K · filed 2026-02-27 |
| 2023-09-30 | $1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.31M derived: sum of 2 quarters · filed 2024-11-07 | $5.18M 10-Q · filed 2024-11-07 | -$8.38M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.26M 10-Q · filed 2024-08-08 | -$10.30M derived: sum of 3 quarters · filed 2025-02-27 | -$15.29M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.86M 10-Q · filed 2024-05-09 | -$11.69M derived: sum of 2 quarters · filed 2025-02-27 | -$16.68M derived: sum of 3 quarters · filed 2025-02-27 | -$11.45M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$13.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$18.55M derived: sum of 2 quarters · filed 2025-02-27 | -$13.31M derived: sum of 3 quarters · filed 2025-02-27 | -$7.00M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$4.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $245.00K derived: sum of 2 quarters · filed 2023-11-03 | $6.55M 10-Q · filed 2023-11-03 | -$1.44M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $5.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $11.54M 10-Q · filed 2023-08-03 | $3.55M derived: sum of 3 quarters · filed 2024-02-27 | $1.34M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $6.31M 10-Q · filed 2023-05-04 | -$1.68M derived: sum of 2 quarters · filed 2024-02-27 | -$3.89M derived: sum of 3 quarters · filed 2024-02-27 | -$24.10M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$10.20M derived: sum of 2 quarters · filed 2024-02-27 | -$30.41M derived: sum of 3 quarters · filed 2024-02-27 | -$28.41M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$22.42M derived: sum of 2 quarters · filed 2022-11-10 | -$20.42M 10-Q · filed 2022-11-10 | -$20.48M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$20.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$18.21M 10-Q · filed 2022-08-11 | -$18.27M derived: sum of 3 quarters · filed 2023-03-01 | -$27.31M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $2.00M 10-Q · filed 2022-05-12 | $1.94M derived: sum of 2 quarters · filed 2023-03-01 | -$7.10M derived: sum of 3 quarters · filed 2023-03-01 | -$6.50M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$9.10M derived: sum of 2 quarters · filed 2023-03-01 | -$8.50M derived: sum of 3 quarters · filed 2023-03-01 | -$7.83M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$9.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$8.44M derived: sum of 2 quarters · filed 2021-11-08 | -$7.77M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.27M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $670.00K 10-Q · filed 2021-05-28 | |||
| 2019-12-31 | $716.00K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |